Scott Westhouse, DO
Ophthalmology · Grand Rapids, MINPI 1306016977
Payments from drug & device makers
Across 414 payments — averaging $1267.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$373K
- Regeneron Healthcare Solutions, Inc.$110K
- Regeneron$9K
- Alimera Sciences, Inc.$7K
- Genentech USA, Inc.$6K
- Roche TCRC, Inc.$5K
- plus $14K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 94 | $373,456 |
| Regeneron Healthcare Solutions, Inc. | 125 | $110,319 |
| Regeneron | 4 | $9,016 |
| Alimera Sciences, Inc. | 21 | $7,097 |
| Genentech USA, Inc. | 31 | $6,055 |
| Roche TCRC, Inc. | 1 | $5,000 |
| Novartis | 14 | $4,396 |
| Apellis Pharmaceuticals, Inc. | 20 | $4,036 |
| US Retina LLC | 11 | $2,352 |
| Astellas Pharma US Inc | 17 | $780 |
| AbbVie(2 entities) | 25 | $742 |
| Coherus Oncology, Inc. | 7 | $375 |
| Bausch & Lomb Americas Inc. | 5 | $192 |
| Eyepoint US, Inc. | 7 | $155 |
| Mallinckrodt Enterprises LLC | 5 | $108 |
| ANI Pharmaceuticals, Inc. | 3 | $83 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $79 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Hoffmann-la Roche Limited | 1 | $64 |
| Amgen(2 entities) | 3 | $55 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $54 |
| Sandoz | 2 | $53 |
| Oyster Point Pharma, Inc. | 2 | $41 |
| Ocular Therapeutix, Inc. | 2 | $38 |
| Biogen | 2 | $38 |
| Biotissue Holdings Inc. | 2 | $31 |
| Dompe US, Inc. | 1 | $27 |
| Neurotech Pharmaceuticals, Inc. | 1 | $22 |
How this compares
$524,729 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Grand Rapids
- Jeffrey ZheutlinGrand Rapids$231K
- Louis GlazerGrand Rapids$157K
- Austen KnappGrand Rapids$16K
- Marcus MuallemGrand Rapids$15K
- Mahdi BashaFraser$2.2M
- Thomas WubbenAnn Arbor$1.2M
- Manjool ShahAnn Arbor$745K
- Gregory KatzYpsilanti$495K
- Cagri BesirliAnn Arbor$441K
- David BrownSaint Joseph$432K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.